Trial Profile
A phase II trial of ACP-103 in patients with sleep maintenance insomnia.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 May 2016
Price :
$35
*
At a glance
- Drugs Pimavanserin (Primary)
- Indications Sleep maintenance insomnia
- Focus Therapeutic Use
- 09 May 2016 New trial record